Calendar Seelos Therapeutics, Inc.

Equities

SEEL

US81577F2083

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
0.2856 USD -5.12% Intraday chart for Seelos Therapeutics, Inc. -15.50% -79.45%

Chart calendar Seelos Therapeutics, Inc.

a.IHaeWSYQ6qnOOobWSXdYmoDsGIxyYfVA3QjwRgOZcqk.SBX4Oldpm56oSfSmcD8ZzLfVV74zNaYFi3-AEU_MKMt3A_8TSn2o2Kld1w~d74d3c467ef26ea7f1250f70c9103cca

Upcoming events on Seelos Therapeutics, Inc.

2024-08-01 Q2 2024 Earnings Release (Projected)
2025-04-24 Q1 2025 Earnings Release (Projected)

Past events on Seelos Therapeutics, Inc.

Today Q1 2024 Earnings Release (Projected)
2024-01-10 08:00 am Extraordinary Shareholders Meeting
2023-11-13 09:00 am Society for Neuroscience Meeting
2023-09-20 08:00 am SLS-002 Phase II Study Results Call
2023-08-13 Q2 2023 Earnings Release
2023-07-18 01:00 pm Investor Meeting - Key Opinion Leader
2023-05-19 03:00 pm American Society of Gene and Cell Therapy Meeting
2023-05-17 Annual General Meeting
2023-05-15 08:00 am Q1 2023 Earnings Release
2023-03-05 Cowen Health Care Conference
2023-02-22 08:00 pm Alzheimer & Parkinson Drug Development Summit
2023-01-08 LifeSci Partners Corporate Access Conference
2022-12-15 01:00 pm Business Update Call
2022-11-15 01:35 pm Guggenheim Immunology and Neurology Conference
2022-11-03 05:45 pm Ataxia Research International Congress
2022-10-05 Cantor Neurology & Psychiatry Conference
2022-09-28 02:45 pm Guggenheim Therapeutics Conference
2022-09-21 Jefferies Innovation in Mental Health Summit
2022-06-10 11:30 am Jefferies Healthcare Conference
2022-05-20 08:00 am Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,38
0,40
-6.25%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
2,20
1,55
42.13%
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-29,7
-23,9
-24.29%
-18,8
-17,2
-8.93%
-61,7
-45,1
-36.76%
-70,9
-68,6
-3.33%
-40,5
-39,5
-2.56%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-51,3
-45,0
-13.84%
-19,1
-16,9
-12.83%
-66,0
-49,6
-33.16%
-73,5
-70,2
-4.71%
-37,9
-39,4
3.9%
Net income
Million USD
Released
Forecast
Spread
-51,3
-45,0
-13.84%
-19,1
-16,9
-12.83%
-66,0
-49,6
-33.16%
-73,5
-70,2
-4.71%
-37,9
-39,4
3.9%
EPS
USD
Released
Forecast
Spread
-75,6
-98,9
23.52%
-12,9
-11,4
-13.16%
-21,9
-16,6
-32.33%
-20,7
-18,9
-9.52%
-7,73
-0,41
-1785.37%
Announcement Date17/03/2011/03/2104/03/2210/03/2306/03/24

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,81
0,00
-
0,34
0,00
-
0,41
0,00
-
0,65
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-27,4
-11,4
-139.15%
-14,0
-18,7
25.27%
-21,2
-15,4
-37.67%
-17,4
-12,5
-39.5%
-18,3
-16,0
-14.44%
-8,93
-13,3
32.81%
-11,0
-10,2
-7.09%
-12,6
-11,5
-9.22%
-8,01
-7,00
-14.44%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-27,3
-11,4
-138.49%
-14,0
-18,7
25.1%
-21,3
-15,4
-37.93%
-19,6
-12,5
-57.14%
-18,7
-16,0
-16.89%
-13,4
-13,2
-1.72%
-29,5
-10,3
-187.65%
10,5
-11,5
191.12%
-5,45
-6,99
22.01%
Net income
Million USD
Released
Forecast
Spread
-27,3
-11,4
-138.49%
-14,0
-18,7
25.1%
-21,3
-15,4
-37.93%
-19,6
-12,5
-57.14%
-18,7
-16,0
-16.89%
-13,4
-13,2
-1.72%
-29,5
-10,3
-187.65%
10,5
-11,5
191.12%
-5,45
-6,99
22.01%
EPS
USD
Released
Forecast
Spread
-8,40
-3,30
-154.55%
-3,90
-5,40
27.78%
-6,00
-4,30
-39.54%
-5,40
-3,40
-58.82%
-5,10
-3,90
-30.77%
-3,60
-3,20
-12.5%
-6,60
-2,85
-131.58%
2,40
-1,80
233.33%

-0,80

Announcement Date04/03/2210/05/2205/08/2210/11/2210/03/2312/05/2311/08/2314/11/2306/03/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SEEL Stock
  4. Calendar Seelos Therapeutics, Inc.